Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Antiproliferative effects of CDK4/6 inhibition in CDK4-amplified human liposarcoma in vitro and in vivo.
[liposarcoma]
Well-differentiated
/
dedifferentiated
liposarcomas
(
WD
/
DDLPS
)
are
among
the
most
common
subtypes
of
soft
tissue
sarcomas
.
Conventional
systemic
chemotherapy
has
limited
efficacy
and
novel
therapeutic
strategies
are
needed
to
achieve
better
outcomes
for
patients
.
The
cyclin-dependent
kinase
4
(
CDK
4
)
gene
is
highly
amplified
in
more
than
95
%
of
WD
/
DDLPS
.
In
this
study
,
we
explored
the
role
of
CDK
4
and
the
effects
of
NVP-LEE
011
(
LEE
011
)
,
a
novel
selective
inhibitor
of
CDK
4
/
CDK
6
,
on
a
panel
of
human
liposarcoma
cell
lines
and
primary
tumor
xenografts
.
We
found
that
both
CDK
4
knockdown
by
siRNA
and
inhibition
by
LEE
011
diminished
retinoblastoma
(
RB
)
phosphorylation
and
dramatically
decreased
liposarcoma
cell
growth
.
Cell-cycle
analysis
demonstrated
arrest
at
G
0
-
G
1
.
siRNA-mediated
knockdown
of
RB
rescued
the
inhibitory
effects
of
LEE
011
,
demonstrating
that
LEE
011
decreased
proliferation
through
RB
.
Oral
administration
of
LEE
011
to
mice
bearing
human
liposarcoma
xenografts
resulted
in
approximately
50
%
reduction
in
tumor
(
18
)
F-
fluorodeoxyglucose
uptake
with
decreased
tumor
biomarkers
,
including
RB
phosphorylation
and
bromodeoxyuridine
incorporation
in
vivo
.
Continued
treatment
inhibited
tumor
growth
or
induced
regression
without
detrimental
effects
on
mouse
weight
.
After
prolonged
continuous
dosing
,
reestablishment
of
RB
phosphorylation
and
cell-cycle
progression
was
noted
.
These
findings
validate
the
critical
role
of
CDK
4
in
maintaining
liposarcoma
proliferation
through
its
ability
to
inactivate
RB
function
,
and
suggest
its
potential
function
in
the
regulation
of
survival
and
metabolism
of
liposarcoma
,
supporting
the
rationale
for
clinical
development
of
LEE
011
for
the
treatment
of
WD
/
DDLPS
.
Diseases
Validation
Diseases presenting
"novel therapeutic strategies are needed to achieve better outcomes for patients"
symptom
liposarcoma
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom